Borrelia persica infection in dogs and cats: clinical manifestations, clinicopathological findings and genetic characterization

por Baneth, Gad, Nachum-Biala, Yaarit, Halperin, Tamar, Hershko, Yizhak, Kleinerman, Gabriela, Anug, Yigal, Abdeen, Ziad, Lavy, Eran, Aroch, Itamar, Straubinger, Reinhard K.
Publicado 2016

Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients

por Shashar, Moshe, Nacasch, Naomi, Grupper, Ayelet, Benchetrit, Sydney, Halperin, Tamar, Erez, Daniel, Rozenberg, Ilan, Shitrit, Pnina, Sela, Yaron, Wand, Ori, Cohen-Hagai, Keren
Publicado 2022

Kinetics of the humoral response 1-year following vaccination with BNT162b2 SARS-CoV-2 vaccine among maintenance hemodialysis patients

por Wand, Ori, Einbinder, Yael, Nacasch, Naomi, Halperin, Tamar, Erez, Daniel, Grupper, Ayelet, Benchetrit, Sydney, Lishner, Michael, Bar-Shai, Amir, Shashar, Moshe, Cohen-Hagai, Keren
Publicado 2022

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer

por Ligumsky, Hagai, Dor, Herut, Etan, Tal, Golomb, Inbal, Nikolaevski-Berlin, Alla, Greenberg, Inbal, Halperin, Tamar, Angel, Yoel, Henig, Oryan, Spitzer, Avishay, Slobodkin, Marina, Wolf, Ido
Publicado 2022

Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients

por Einbinder, Yael, Perl, Jeffrey, Nacasch, Naomi, Bnaya, Alon, Shavit, Linda, Erez, Daniel, Shashar, Moshe, Halperin, Tamar, Grupper, Ayelet, Benchetrit, Sydney, Wand, Ori, Cohen-Hagai, Keren
Publicado 2022

Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vac...

por Tau, Luba, Hagin, David, Freund, Tal, Halperin, Tamar, Adler, Amos, Marom, Rotem, Ahsanov, Svetlana, Matus, Natasha, Levi, Inbar, Gerber, Gal, Lev, Shir, Ziv-Baran, Tomer, Turner, Dan
Publicado 2023

SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical Center

por Tau, Luba, Turner, Dan, Adler, Amos, Marom, Rotem, Ahsanov, Svetlana, Matus, Natasha, Levi, Inbar, Gerber, Gal, Lev, Shir, Ziv-Baran, Tomer, Hagin, David, Freund, Tal, Grupper, Ayelet, Halperin, Tamar
Publicado 2022

Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients

por Pri-Paz Basson, Yael, Tayer-Shifman, Oshrat E., Naser, Rawand, Tartakover Matalon, Shelly, Kimhi, Oded, Gepstein, Raz, Halperin, Tamar, Ziv-Baran, Tomer, Ziv, Amit, Parikh, Roma, Kivity, Shaye, Levy, Yair
Publicado 2022